Bank of New York Mellon Corp - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 103 filers reported holding ALBIREO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$1,869,179
+12.7%
86,496
+0.9%
0.00%
Q3 2022$1,659,000
-4.1%
85,722
-1.6%
0.00%
Q2 2022$1,730,000
-40.0%
87,124
-9.8%
0.00%
-100.0%
Q1 2022$2,881,000
+47.4%
96,568
+15.0%
0.00%
Q4 2021$1,955,000
-25.7%
83,968
-0.5%
0.00%
-100.0%
Q3 2021$2,632,000
-6.7%
84,356
+5.2%
0.00%0.0%
Q2 2021$2,820,000
-13.9%
80,158
-13.7%
0.00%0.0%
Q1 2021$3,276,000
+8.3%
92,922
+15.2%
0.00%0.0%
Q4 2020$3,024,000
+70.9%
80,629
+52.1%
0.00%
Q3 2020$1,769,000
+23.3%
53,012
-2.1%
0.00%
Q2 2020$1,435,000
+95.8%
54,170
+21.1%
0.00%
Q1 2020$733,000
-20.6%
44,744
+23.2%
0.00%
Q4 2019$923,000
+37.6%
36,315
+8.2%
0.00%
Q3 2019$671,000
-35.2%
33,565
+4.6%
0.00%
Q2 2019$1,035,000
-15.2%
32,092
-15.3%
0.00%
Q1 2019$1,221,000
+32.6%
37,888
+0.9%
0.00%
Q4 2018$921,000
-20.2%
37,552
+7.2%
0.00%
Q3 2018$1,154,000
+0.8%
35,023
+8.6%
0.00%
Q2 2018$1,145,000
+231.9%
32,263
+205.0%
0.00%
Q1 2018$345,000
+59.7%
10,578
+25.4%
0.00%
Q4 2017$216,0008,4380.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders